Novartis is embracing the digital revolution in health with a new edition of Cancer Start-up Program, its initiative that seeks to find solutions for a better approach to cancer patients.

Novartis is embracing the digital revolution in health with a new edition of Cancer Start-up Program, its initiative that seeks to find solutions for a better approach to cancer patients

Novartis

Novartis is eager to contribute to this new era of innovation in healthcare. Do you want to be part of the change?

Novartis is one of the leading health care companies providing solutions to the changing needs of society around the world, with a presence in more than 140 countries. Its aim is to reimagine medicine to ensure that people enjoy a better quality of life.

The company uses scientific innovation and disruptive technology to address the great healthcare challenges that society faces. It therefore works constantly to develop innovative treatments that can benefit as many people as possible.

Novartis Biome

Novartis Biome is Novartis’ open innovation laboratory.

Its purpose is to drive health-focused technology companies and people who are passionate about transforming the sector using data and digital tools.

What is the Cancer
Start-up Program?

In the current technological context, the fight against cancer requires, more than ever, a holistic approach that unites all the stakeholders involved in managing this disease.

Novartis Oncology joins this digital health revolution through Cancer Start-up Program, its initiative that seeks technological and digital solutions to improve the comprehensive management of oncology patients and address the needs of healthcare professionals.

Its mission is to respond to the main challenges of healthcare in the prevention, diagnosis and monitoring of the disease, and to promote more rapid and efficient management that benefits both patients and healthcare providers.

Challenge

How can technology be used to improve the comprehensive management of oncology patients and address the needs of healthcare professionals in preventing, diagnosing and monitoring the disease?

New technologies and the speed with which information is generated, distributed and consumed facilitate a democratization of knowledge and access to new devices for cancer prevention, diagnosis and monitoring. However, there is rarely an inclusive vision of all this information and technology available that enhances the role of each actor, which limits the opportunities to interact and improve the management of the disease throughout its stages. 

Novartis is looking for solutions focusing on the integral management of oncology patients that facilitate the work of healthcare professionals and have an impact on all those involved throughout the disease in the prevention, diagnosis and monitoring stages.

The proposals the company hopes to receive are divided into three pillars or use cases.

Use cases

Prevention and
pre-diagnosis

Phase

Prevention and
pre-diagnosis

Target:

Healthcare professionals and patients

What is the objective?

To assist healthcare professionals with sharing preventative information and with the early diagnosis of oncology patients.

 

What are we looking for?

Technology Proposals/Projects that guarantee access and traceability of information and that make it possible to establish predictive diagnosis models, as well as actively sharing  preventative information that involves patients.

Diagnosis and managing emotions

Phase

Diagnosis

Target:

Healthcare professionals, patients and their loved ones

What is the objective?

To facilitate the emotional management of patients when the disease is diagnosed and as they adapt to living with it.

 

What are we looking for?

Technology Proposals/Projects that facilitate accompanying patients and their loved ones at the time of diagnosis, as well as the communication processes and subsequent follow-up to ease their adaptation to the disease.

Remote
monitoring

Phase

Monitoring

Target:

Healthcare professionals, patients

What is the objective?

To promote and optimize remote patient monitoring in a personalized manner that brings together all the specialists involved in this follow-up.

 

What are we looking for?

Technology Proposals/Projects that encourage self-management of the disease by patients and in collaboration with the multidisciplinary team of specialists around them, as well as of the processes associated with living with it.

Value proposition

Impact:

Conceptualization, development and implementation of the solution in a real environment via a pilot and/or commercial agreement financed by Novartis in collaboration with a leading healthcare institution in Spain.

Grow:

Validation of the start-up’s value proposition and visibility in the healthcare environment and in the technology ecosystem to boost the growth of the project and make it accessible and scalable to healthcare professionals and patients around the globe.

Discover:

Support from Novartis professionals and from the initiative’s partners to develop the pilot project, as well as access to industry knowledge on regulatory, legal and operational matters.

Connect:

Access to Novartis’ customer network in Spain to work alongside hospitals, institutions and healthcare centers, as well as leading medical professionals.

Who can take part?

Key dates

Registration and pre-screening

21 June to 15 September.

Evaluation

20 to 30 September.

Selection of finalists

4 to 8 October.

Winner selection event

19 October.

Communication of winners

November.

Start of negotiations

January 2022.

*All dates are tentative and may be subject to change

© 2021 Novartis Farmacéutica, SA

This website is intended for users in Spain

ES2106088791